# Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas

> **NCT06454097** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DIAGNOSTIC_TEST:** Assess the response glioma to radiochemotherapy using radiogenomics-based AI model

## Key facts

- **NCT ID:** NCT06454097
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-23
- **Primary completion:** 2024-11-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06454097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06454097, "Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06454097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*